Auteur D. HORYNIAK

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Behavioural interventions for preventing hepatitis C infection in people who inject drugs: A global systematic review

R. SACKS-DAVIS ; D. HORYNIAK ; J. GREBELY ; M. HELLARD | 2012
Dans International Journal of Drug Policy (Vol.23, n°3, May 2012) Article : Périodique

BACKGROUND: A systematic review was conducted to determine whether behavioural interventions are effective in preventing transmission of hepatitis C virus (HCV) amongst people who inject drugs. METHODS: Medline, EMBASE, the Cochrane Clinical T[...]

Plus d'info

Ajouter à la sélection

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

P. K. NELSON ; B. M. MATHERS ; B. COWIE ; H. HAGAN ; D. C. DES JARLAIS ; D. HORYNIAK ; L. DEGENHARDT | 2011
Dans Lancet (The) (Vol.378, n°9791, Aug 13, 2011) Article : Périodique

BACKGROUND: Injecting drug use is an important risk factor for transmission of viral hepatitis, but detailed, transparent estimates of the scale of the issue do not exist. We estimated national, regional, and global prevalence and population siz[...]

Plus d'info

Ajouter à la sélection

How do drug market changes affect characteristics of injecting initiation and subsequent patterns of drug use? Findings from a cohort of regular heroin and methamphetamine injectors in Melbourne, Australia

D. HORYNIAK ; M. STOOVE ; L. DEGENHARDT ; C. AITKEN ; T. KERR ; P. DIETZE | 2015
Dans International Journal of Drug Policy (Vol.26, n°1, January 2015) Article : Périodique

Background: Changes in drug market characteristics have been shown to affect drug use patterns but few studies have examined their impacts on injecting initiation experiences and subsequent patterns of injecting drug use (IDU). Methods: We coll[...]

Plus d'info

Ajouter à la sélection

Lien externe

The experience of initiating injection drug use and its social context: a qualitative systematic review and thematic synthesis

A. GUISE ; D. HORYNIAK ; J. MELO ; R. MCNEIL ; D. WERB | 2017
Dans Addiction (Vol.112, n°12, December 2017) Article : Périodique

Background and aim: Understanding the experience of initiating injection drug use and its social contexts is crucial to inform efforts to prevent transitions into this mode of drug consumption and support harm reduction. We reviewed and synthesi[...]

Plus d'info

Ajouter à la sélection

The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia

D. HORYNIAK ; P. DIETZE ; B. LARANCE ; A. WINSTOCK ; L. DEGENHARDT | 2011
Dans International Journal of Drug Policy (Vol.22, n°2, March 2011) Article : Périodique

BACKGROUND Diversion and injection of buprenorphine (Subutex®) and buprenorphine-naloxone (Suboxone®) have been well documented. Recent international research and local anecdotal evidence suggest that these medications are also used by other rou[...]

Plus d'info

Ajouter à la sélection